|
Scrip
@
PharmaScrip
Global
|
|
Scrip goes beyond the headlines and focuses on delivering insight & analysis on the whole of the drug discovery, development and product life cycle value chain.
|
|
|
31.296
Tweetovi
|
1.672
Pratim
|
19.578
Osobe koje vas prate
|
| Tweetovi |
|
Scrip
@PharmaScrip
|
4 min |
|
Best Practices In Seasonal Vaccine Efficacy Studies: Tips For Successful Planning And Execution
bit.ly/382paG0 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
1 h |
|
Executives On The Move: Bayer Names Upcoming Information Chief And Legal Hires At Eli Lilly And CytoDyn
bit.ly/2H0g1St #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
1 h |
|
Did you know that the reach of #pharmaintelligence is unparalleled with over 350 experts supplying comprehensive news & #analysis. Find out how to boost your sales with #pharmaintelligence here bit.ly/3aXiURE pic.twitter.com/tY8o0gIjuV
|
||
|
|
||
|
Scrip
@PharmaScrip
|
2 h |
|
Zydus Cadila Explores Orphan Drug Indication For NASH Candidate
bit.ly/2Uva3AU #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
3 h |
|
Biogen's Tecfidera Safe Following IPR Decision – For Now
bit.ly/31zygI6 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
4 h |
|
Merck: It’s Not Just Keytruda Driving Future Growth
bit.ly/2UFjsX1 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5 h |
|
Merck To Spin Out A New Company, Following Industry's Downsizing Trend
bit.ly/372zKeX #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
17 h |
|
Pharma Is Priority As GSK Confirms Split With Consumer
bit.ly/398w9gM #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
18 h |
|
Novo Nordisk’s Positive Q4 Update Highlights Pipeline Plans
bit.ly/2S0GbL5 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
19 h |
|
Cell And Gene Therapy Manufacturing: Catalent Snaps Up MaSTherCell
bit.ly/31xD40C #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
20 h |
|
From too much data to the stuggles of patient recruitment, these are a few of the issues that came to light in a recent study by #Medidata. Learn more of the solution here bit.ly/38OLjI6 pic.twitter.com/wh0SCLV5NC
|
||
|
|
||
|
Scrip
@PharmaScrip
|
22 h |
|
Roche Has Blockbusters In Its Pipeline – But Demurs On Predicting Hits
bit.ly/2SkGcIT #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
23 h |
|
Leo Sets Up For A David & Goliath Showdown In Atopic Dermatitis
bit.ly/2vSg5l3 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
Coronavirus Notebook: Regeneron, HHS To Develop Antibody
bit.ly/2RZfJS7 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
Ranitidine Recall Dents GSK India, Which Mulls Plant Sale
bit.ly/36ZNHu7 #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
How are originator and #generics industries diverging and to what extent to innovators want to play in the hybrid space? Download this article to find out bit.ly/2RwmLh6 pic.twitter.com/jqLkiCg0W0
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
Japan Pharma Unconcerned About Virus Impact - For Now
bit.ly/31wqyyb #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
A recent survey by #NTTDATA has shed light on the potential for utlizing #machinelearning in precision-based #clinicaltrials. Register to learn more at our #webinar bit.ly/2NTRpyD pic.twitter.com/dO9PsTZJM2
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out
bit.ly/398npHt #PharmaScrip
|
||
|
|
||
|
Scrip
@PharmaScrip
|
5. velj |
|
Leo Sets Up For A Samson & Goliath Showdown In Atopic Dermatitis
bit.ly/2GSbrFY #PharmaScrip
|
||
|
|
||